Literature DB >> 21395652

Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study.

Christopher Beer1, Zoë Hyde, Osvaldo P Almeida, Paul Norman, Graeme J Hankey, Bu B Yeap, Leon Flicker.   

Abstract

AIM: To determine the prevalence of potentially suboptimal medication use and association with adverse outcomes.
METHODS: A prospective, observational cohort study of 4260 community-dwelling older men from Perth, Western Australia (mean age of 77 ± 3.6 years) was conducted. Follow-up was for 4.5 years (or until death, if sooner). Cox proportional hazard models were used to explore associations between suboptimal medication use and prospective clinical outcomes. Logistic regression analyses were used to explore predictors of a fall in the previous 12 months.
RESULTS: Use of potentially inappropriate medicines (48.7%), polypharmacy (≥5 medications, 35.8%) and potential under-utilization (56.7%) were highly prevalent, and overall 82.3% of participants reported some form of potentially suboptimal medication use. A self-reported history of falls in the previous 12 months was independently associated with the number of medicines taken (odds ratio [OR]= 1.06, 95% confidence interval [CI] 1.02, 1.09) and use of one or more potentially inappropriate medicines (OR = 1.23, 95% CI 1.04, 1.45). After adjusting for age, co-morbidity, smoking status, body mass index, hypertension and educational attainment, the number of medicines reported was associated with admission to hospital (hazard ratio [HR]= 1.04, 95% CI 1.03, 1.06), cardiovascular events (HR = 1.09, 95% CI 1.06, 1.12) and all cause mortality (HR = 1.04, 95% CI 1.00, 1.07). Use of one or more potentially inappropriate medicines was associated with admission to hospital (HR = 1.16, 95% CI 1.08, 1.24). Potential under-utilization was associated with cardiovascular events (HR = 1.20, 95% CI 1.03, 1.40).
CONCLUSIONS: These data suggest that both medication over-use and under-use occur frequently among older men and may be harmful.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395652      PMCID: PMC3080648          DOI: 10.1111/j.1365-2125.2010.03875.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  Cohort Profile: The Health In Men Study (HIMS).

Authors:  Paul E Norman; Leon Flicker; Osvaldo P Almeida; Graeme J Hankey; Zoë Hyde; Konrad Jamrozik
Journal:  Int J Epidemiol       Date:  2008-03-03       Impact factor: 7.196

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Defining inappropriate practices in prescribing for elderly people: a national consensus panel.

Authors:  P J McLeod; A R Huang; R M Tamblyn; D C Gayton
Journal:  CMAJ       Date:  1997-02-01       Impact factor: 8.262

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Population-based linkage of health records in Western Australia: development of a health services research linked database.

Authors:  C D Holman; A J Bass; I L Rouse; M S Hobbs
Journal:  Aust N Z J Public Health       Date:  1999-10       Impact factor: 2.939

7.  Is it possible to reduce polypharmacy in the elderly? A randomised, controlled trial.

Authors:  K H Pitkala; T E Strandberg; R S Tilvis
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

8.  Association between falls in elderly women and chronic diseases and drug use: cross sectional study.

Authors:  Debbie A Lawlor; Rita Patel; Shah Ebrahim
Journal:  BMJ       Date:  2003-09-27

9.  Questionable prescribing for elderly patients in Quebec.

Authors:  R M Tamblyn; P J McLeod; M Abrahamowicz; J Monette; D C Gayton; L Berkson; W D Dauphinee; R M Grad; A R Huang; L M Isaac
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

10.  Medication undertreatment in assisted living settings.

Authors:  Philip D Sloane; Ann L Gruber-Baldini; Sheryl Zimmerman; Mary Roth; Lea Watson; Malaz Boustani; Jay Magaziner; J Richard Hebel
Journal:  Arch Intern Med       Date:  2004-10-11
View more
  41 in total

Review 1.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estévez
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

Review 3.  Underprescription of medications in older adults: causes, consequences and solutions-a narrative review.

Authors:  F Lombardi; L Paoletti; B Carrieri; G Dell'Aquila; M Fedecostante; M Di Muzio; A Corsonello; F Lattanzio; A Cherubini
Journal:  Eur Geriatr Med       Date:  2021-03-11       Impact factor: 1.710

4.  Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Authors:  Alex Secora; G Caleb Alexander; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

5.  Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.

Authors:  Rupert A Payne; Gary A Abel; Anthony J Avery; Stewart W Mercer; Martin O Roland
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

Review 6.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Authors:  Emily Reeve; Danijela Gnjidic; Janet Long; Sarah Hilmer
Journal:  Br J Clin Pharmacol       Date:  2015-12       Impact factor: 4.335

Review 7.  Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.

Authors:  Janani Thillainadesan; Danijela Gnjidic; Sarah Green; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

8.  Association between number of medications and mortality in geriatric inpatients: a Danish nationwide register-based cohort study.

Authors:  Kristoffer Kittelmann Brockhattingen; Pavithra Laxsen Anru; Tahir Masud; Mirko Petrovic; Jesper Ryg
Journal:  Eur Geriatr Med       Date:  2020-09-09       Impact factor: 1.710

9.  Quality of prescribing in community-dwelling elderly patients in France: an observational study in community pharmacies.

Authors:  E Bourcier; F Mille; V Brunie; V Korb-Savoldelli; C Lafortune; M Buyse; C Fernandez; P Hindlet
Journal:  Int J Clin Pharm       Date:  2017-09-14

Review 10.  Medications associated with falls in older people: systematic review of publications from a recent 5-year period.

Authors:  Hyerim Park; Hiroki Satoh; Akiko Miki; Hisashi Urushihara; Yasufumi Sawada
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.